Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCAT 2023 | Cure2Children: delivering transplant therapy for SCD and thalassemia in developing countries

Lawrence Faulkner, MD, Cure2Children Foundation, Florence, Italy, speaks on his pioneering work to deliver affordable treatment options for children with sickle cell disease (SCD) and thalassemia in developing countries, particularly in southeast Asia. Dr Faulkner highlights the importance of focusing resources on efforts to provide curative bone marrow transplantation treatment. This interview was recorded at the 18th Annual Scientific Conference on Sickle Cell and Thalassemia (ASCAT) 2023, held in London, UK.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.